Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
1.670
-0.140 (-7.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Moleculin Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5 | 29 | 30 | 53 | 50 | 42 | |
| Market Cap Growth | -36.61% | -5.48% | -42.91% | 5.47% | 20.43% | 48.31% | |
| Enterprise Value | -4 | 5 | -20 | -22 | 38 | 27 | |
| Last Close Price | 1.67 | 12.88 | 15.90 | 27.90 | 71.74 | 82.36 | |
| PB Ratio | 0.67 | 1.10 | 0.58 | 0.67 | 2.84 | 2.69 | |
| P/TBV Ratio | - | 1.92 | 0.74 | 0.78 | 7.62 | 9.46 | |
| Debt / Equity Ratio | 0.07 | 0.02 | 0.01 | 0.00 | 0.02 | 0.02 | |
| Quick Ratio | 1.68 | 3.47 | 8.96 | 19.59 | 5.20 | 3.01 | |
| Current Ratio | 2.08 | 3.86 | 9.46 | 20.02 | 5.89 | 3.78 | |
| Return on Equity (ROE) | -141.49% | -76.07% | -44.25% | -32.85% | -104.14% | -88.50% | |
| Return on Assets (ROA) | -57.45% | -38.73% | -27.06% | -25.38% | -45.48% | -48.87% | |
| Return on Capital (ROIC) | -82.70% | -46.71% | -29.06% | -29.54% | -72.61% | -72.48% | |
| Earnings Yield | -601.42% | -103.79% | -95.65% | -29.90% | -34.44% | -31.56% | |
| FCF Yield | -484.32% | -84.46% | -91.30% | -35.69% | -36.01% | -41.22% | |
| Buyback Yield / Dilution | -37.97% | -3.60% | -6.43% | -172.97% | -45.07% | -57.20% | |
| Total Shareholder Return | -37.97% | -3.60% | -6.43% | -172.97% | -45.07% | -57.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.